Class 424/492 - Gelatin

Subclass of Class 424 - Drug, bio-affecting and body treating compositions
Definition: Subject matter in which the protein is gelatin.
No. of applications: 34
Last issue date: 05/24/2012

Application No.	Application Title	Issue Date
20120128780	NANOPARTICULATE BISPHOSPHONATE COMPOSITIONS Nanoparticulate bisphosphonate compositions, having an effective average particle size of less than 2000 nm, are described. The compositions are useful in treating bone resorption in a mammal....	05/24/2012
20120040008	PHARMACEUTICAL COMPOSITIONS OF METABOTROPIC GLUTAMATE 5 RECEPTOR (MGLU5) ANTAGONISTS Pharmaceutical compositions of metabotropic glutamate 5 receptor (mGlu5) antagonists or a pharmacologically acceptable salt thereof are disclosed. The compositions contain the therapeutic active compound with non-ionic polymer and ionic polymer, binder and fillers in ei...	02/16/2012
20120021058	PROCESS FOR MAKING DRY AND STABLE HEMOSTATIC COMPOSITIONS Described is a process for making a dry and stable hemostatic composition, said process comprising a) providing a dry g...	01/26/2012
20120015038	ENTERICALLY COATED CYSTEAMINE, CYSTAMINE AND DERIVATIVES THEREOF The disclosure provides oral cysteamine and cystamine formulations useful for treating cystinosis and neurodegenerative diseases and disorders. The formulations provide controlled release compositions that improve quality of life and reduced side-effects....	01/19/2012
20110256229	RAPID-ACTING PHARMACEUTICAL COMPOSITION A pharmaceutical composition for the treatment of acute disorders is described. The composition comprises an essentially water-free, ordered mixture of at least one pharmaceutically active agent in the form of microparticles which are adhered to the surfaces of carrier ...	10/20/2011
20110236494	CIPROFLOXACIN ORAL SUSPENSION The present invention relates to oral taste masked pharmaceutical composition comprising ciprofloxacin or salts or esters thereof. It further relates to processes of preparing it....	09/29/2011
20110206771	Encapsulated functional fine particle composition capable of spraying and preparation method thereof Provided is an encapsulated functional fine particle composition capable of spraying that is useful for hemostasis and wound protection and allows a patient to treat the wound by oneself. Additionally, the composition can be rapidly applied on a large wound during an op...	08/25/2011
20110165256	COMPOSITIONS AND METHODS FOR TREATMENT OF HYPERPLASIA In accordance with the present invention, there are provided methods for treating hyperplasia in a subject in need thereof. In another aspect of the invention, there are provided methods for reducing neointimal hyperplasia associated with vascular interventional procedu...	07/07/2011
20100266705	NANOPARTICULATE MEGESTROL FORMULATIONS The present invention is directed to nanoparticulate compositions comprising megestrol. The megestrol particles of the composition have an effective average particle size of less than about 2000 nm....	10/21/2010
20100260858	DRUG DELIVERY COMPOSITION A composition for delivery of a drug is disclosed. The composition has a semipermeable coating, particles of a medicament having an effective average particle size of less than or about 2 μm and at least one surface stabilizer adsorbed on the surface of the medicament ...	10/14/2010
20100260842	PSEUDOEPHEDRINE PHARMACEUTICAL FORMULATIONS Controlled-release pharmaceutical formulations comprising pseudoephedrine or any of its pharmaceutically acceptable salts, processes for preparing the pharmaceutical formulations, and methods of using the formulations....	10/14/2010
20100233276	COMPOSITIONS IN POWDER FORM MADE OF SOFT AGGLOMERATES OF A MICRONIZED DRUG AND OF A TWO-COMPONENTS EXCIPIENT, AND PROCESS FOR THEIR PREPARATION The described agglomeration of drug microparticles blended with excipient microparticles is a technique for the size enlargement of micronized products that could be damaged by granulation or compaction techniques. These agglomerates can be used as oral prompt or delaye...	09/16/2010
20100221330	BUOYANT FORMULATIONS OF BETAINE An oral control release formulation for releasing at least one betaine after oral administration to a human, said formulation comprising at least one pharmaceutically acceptable means ensuring an at least partial floating of the formulation releasing at least one betain...	09/02/2010
20100209498	PHARMACEUTICAL COMPOSITIONS OF DULOXETINE The present invention relates to pharmaceutical compositions of duloxetine or pharmaceutically acceptable salts thereof, and processes for their preparation....	08/19/2010
20100209519	PHARMACEUTICAL COMPOSITION FOR INHALATION DELIVERY AND FABRICATION METHOD THEREOF A pharmaceutical composition for inhalation delivery is provided, including drugs and a gelatin nanoparticle encapsulating the drugs to form a drug-gelatin nanocomplex, wherein the surface of the gelatin nanoparticle is modified with cell-targeting molecules. A method f...	08/19/2010
20100173002	Microcapsules with improved shells Disclosed are microcapsules and methods for preparing and using them, as well as methods for improving various properties of microcapsules like impermeability....	07/08/2010
20100166871	VERMIN POISON Use of an orally or nasally available formulation of Tretazicar for poisoning vermin. An orally available or nasally available formulation of Tretazicar, wherein in the orally available formulation the Tretazicar is protected from acid hydrolysis, and provided that the ...	07/01/2010
20100021549	Microparticle oral form useful for the modified release of nanoparticles The present invention aims to propose novel microparticle oral forms for the modified release of active ingredient(s), in particular protein or peptide in nature. It also relates to the uses, in particular therapeutic or cosmetic, of these microparticle oral forms....	01/28/2010
20090238887	Highly Impact-Resistant Granules The present invention provides highly impact-resistant, water-soluble or water dispersible, low-dust granules comprising an active ingredient and methods for obtaining the same....	09/24/2009
20080318788	Microcapsule A microcapsule comprising an active component encapsulated therein, and comprising a particulate matter located in a wall thereof to render the wall permeable. Such microcapsules can be used in a variety of applications including agrochemical applications, which are als...	12/25/2008
20080292611	NOVEL METHODS OF TREATMENT AND DELIVERY MODES The invention relates to a novel method of administration, and device employed in the method, for administering a treatment species to the lungs of a recipient patient. The method involves introducing the device of the invention to the venous system of the patient, the ...	11/27/2008
20080260843	TRANSPULMONARY COMPOSITION It is an object of the present invention to provide a transpulmonary preparation wherein physiologically active ingredient can be stably retained and which has high absorption efficacy and gives low damage to tissue. The present invention provides a transpulmonary prepa...	10/23/2008
20080253961	Formulation of Active Agent Loaded Activated PLGA Nanoparticles for Targeted Cancer Nano-Therapeutics The present invention includes compositions and methods of making an activated polymeric nanoparticle for targeted drug delivery that includes a biocompatible polymer and an amphiphilic stabilizing agent non-covalently associated with a spacer compound that includes at ...	10/16/2008
20080206316	Chromium-Fatty Acid Compounds and Methods of Making and Using Thereof Disclosed are compounds comprising one or more chromium atoms bonded to one or more fatty acids. Also disclosed are nutritional supplements, pharmaceutical formulations, delivery devices, and foodstuffs comprising the disclosed compounds. Methods of using the disclosed ...	08/28/2008
20080152719	Multiparticulate Pharmaceutical Form Comprising Pellets With a Matrix Which Influences the Delivery of a Modulatory Substance The invention relates to a multiparticulate pharmaceutical form, comprising pellets with a multilayer structure for controlled active ingredient release, comprising a) optionally a neutral core (nonpareilles), b) an inner controlling layer comprising a substance having ...	06/26/2008
20080063725	Prolonged-release multimicroparticulate oral pharmaceutical form Modified-release multimicroparticulate pharmaceutical form capable of maintaining the modified release of the active principle in an alcoholic solution and of resisting attempts at misuse. ...	03/13/2008
20070264326	Anti-misuse oral microparticle medicinal formulation The field of the present invention is that of solid microparticulate analgesic oral medicines. The invention is that of providing novel analgesic medicines which allow at the same time the prevention of misuse and of addiction to certain analgesics, and/or the control o...	11/15/2007
20050282763	Methods of treating bladder disorders Methods of treating bladder disorders, including bladder cancer and inflammatory bladder diseases such as interstitial cystitis are disclosed. The methods include identifying a mammal that has or is at risk for having a bladder disorder and administering isolated nuclei...	12/22/2005
20050266093	Nanogene therapy for cell proliferation disorders The present invention concerns particles comprising a chitin component, such as chitosan or a derivative thereof, associated with a polynucleotide encoding an interferon (IFN) molecule, 2-5′ oligoadenylate synthetase (2-5 AS), or a combination thereof. Preferably, the...	12/01/2005
20050260276	Methods and articles for the delivery of therapeutic agents Articles and methods for the delivery of drugs and/or nucleic acids. Articles including a nanoparticle are provided that may be used for the delivery of a drug, a nucleic acid, or both, to a subject. The articles may be of polymeric material and may self-assemble. ...	11/24/2005
20050233968	Polyamino acid-based insulin preparation This invention relates to sustained release preparations of insulin comprising polyamino acid particles, insulin and one or more preservative agents, and a method of preparing such preparations. ...	10/20/2005
20050226937	Use of hyaluronic acid polymers for mucosal delivery of vaccine and adjuvants Compositions are provided which include hyaluronic acid derivatives in combination with vaccine antigens, and optionally adjuvants, for mucosal delivery. Also provided are methods of making the compositions, as well as methods of immunization using the same. ...	10/13/2005
20050226938	Nanoparticles from chitosan Methods are disclosed for preparing crosslinked core and core-shell nanoparticle polymers from chitosan. The final products of the present invention may be used as detergents and as additives for pharmaceutical composition and for drug delivery, and DNA carrier system. ...	10/13/2005
20050226936	Method of soft tissue augmentation Particles according to the invention are made of a viscoelastic medium, are injectable gel particles, and have a size, when subjected to a physiological salt solution, in the range of from 1 to 5 mm. The particles are useful in a soft tissue augmentation implant. The im...	10/13/2005

PatentStorm

Quotables

PatentStorm News

Class 424/492 - Gelatin